Zhang, Meili <br/><br/>
Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma.  [electronic resource] 

 -  Cancer biotherapy & radiopharmaceuticals  Jun 2009 
 - 303-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1557-8852 
<br/><br/><label>Standard No.: </label>10.1089/cbr.2008.0577  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Humanized<br/>Antibody Specificity--immunology<br/>Cell Line, Tumor<br/>Daclizumab<br/>Disease-Free Survival<br/>Endocytosis--immunology<br/>Female<br/>Humans<br/>Immunoglobulin G--metabolism<br/>Immunosuppressive Agents--metabolism<br/>Interleukin-2 Receptor alpha Subunit--immunology<br/>Kaplan-Meier Estimate<br/>Lymphoma--pathology<br/>Maximum Tolerated Dose<br/>Mice<br/>Mice, Nude<br/>Radioimmunotherapy--methods<br/>Xenograft Model Antitumor Assays<br/>Yttrium Radioisotopes--therapeutic use